What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.
Bleeding and clotting disorders are conditions that can impact both men and women, but women face unique issues related to these disorders because of the potential effects on their reproductive health and quality of life. Current data indicates that as many as 1% of women in the United…
Miriam Merad, MD, PhD, an esteemed immunologist at the Icahn School of Medicine at Mount Sinai, has been elected to the National Academy of Medicine (NAM) in recognition of her pioneering contributions to the fields of immunology and cell biology. Dr. Merad was elected for her transformational discoveries, establishing for the first time that tissue-resident macrophages have distinct origins, maintain their lineage separately from adult hematopoiesis, and possess unique functions that enhance tissue health, repair, infection defense, and impact tumor outcomes. She is the Mount Sinai Professor in Cancer Immunology, Chair of the Department of Immunology and Immunotherapy, Director of the Marc and Jennifer Lipschultz Precision Immunology Institute, and Director of the Human Immune Monitoring Center at Icahn Mount Sinai.
NEW YORK, Oct. 9, 2023 /PRNewswire-PRWeb/ — Miriam Merad, MD, PhD, an esteemed immunologist at the Icahn School of Medicine at Mount Sinai, has been elected to the National Academy of Medicine (NAM) in recognition of her pioneering contributions to the fields of immunology and cell biology.
Dr. Merad was elected for her transformational discoveries, establishing for the first time that tissue-resident macrophages have distinct origins, maintain their lineage separately from adult hematopoiesis, and possess unique functions that enhance tissue health, repair, infection defense, and impact tumor outcomes.
She is the Mount Sinai Professor in Cancer Immunology, Chair of the Department of Immunology and Immunotherapy, Director of the Marc and Jennifer Lipschultz Precision Immunology Institute, and Director of the Human Immune Monitoring Center at Icahn Mount Sinai.
With this appointment, Dr. Merad joins an elite group of distinguished international scientists alongside 100 new members this year. Election to the Academy is considered one of the highest honors a scientist can receive in health and medicine and recognizes individuals who have demonstrated outstanding professional achievement and commitment to service.
“This honor underscores Dr. Merad’s profound impact on these fields,” said Dennis S. Charney, MD, Anne and Joel Ehrenkranz Dean of Icahn Mount Sinai and President for Academic Affairs of the Mount Sinai Health System. “Dr. Merad’s groundbreaking discoveries have reshaped the landscape of medical treatments, while her ongoing work continues to uncover the intricate responses of the human immune system to disease.”
In a 2010 Science study, Dr. Merad revealed that tissue-resident embryonic precursors give rise to macrophages, large white blood cells that play crucial roles in organ health and disease. This landmark research, cited thousands of times, has reshaped immunology textbooks and ignited an effort worldwide to explore tissue-resident macrophages in all areas of medicine. Dr. Merad’s own team has revealed the role of the different macrophage lineages in cancer progression, treatment response, and inflammatory bowel disease in prominent journals, including Science, Cell, and Nature.
She has also made significant contributions to research on dendritic cells, a group of cells that control adaptive immunity. She identified a new subset of dendritic cells that has now become a key target to enhance viral and antitumor immunity. In a May 2020 Nature study, her team uncovered new therapeutic targets to boost dendritic cell-mediated antitumor immunity, and in a more recent paper also published in Nature this year, showed that this new therapeutic target can help treat patients with lung cancer.
Dr. Merad has transformed Mount Sinai into a global hub for studying the human immune system. She established the cutting-edge Human Immune Monitoring Center (HIMC), a world-leading research facility using single-cell technology to investigate immune cell contributions to human diseases and treatments. HIMC participates in consortia funded by the National Institutes of Health. This center is now pivotal in identifying new immune targets of cancer and inflammatory diseases.
“I am deeply humbled to be part of the National Academy of Medicine. Being elected is an incredible honor, and I’m proud to represent Mount Sinai,” said Dr. Merad, who joined Mount Sinai’s faculty in 2004. Raised by parents who were both scientific and medical professionals educated in France and practicing in Algeria, she was instilled with a deep respect for the transformative potential of science. She also attributes her success to Mount Sinai, which she said has provided her with the freedom to grow and pursue her research. Dr. Merad emphasizes the institution’s culture of empowering junior faculty and young scientists: “If you aspire to innovate early in your career, Mount Sinai is the place to be.”
The election of Dr. Merad brings Mount Sinai’s total membership in the prestigious group to 26 current and emeritus faculty members. The others are Joseph D. Buxbaum, PhD • Yvette Calderon, MD, MS • Neil S. Calman, MD • Brendan Carr, MD, MS • Dennis S. Charney, MD • Judy Cho, MD • Kenneth L. Davis, MD • Robert J. Desnick, MD, PhD • Angela Diaz, MD, MPH • Valentin Fuster, MD, PhD • Bruce Gelb, MD • Alison M. Goate, DPhil • Yasmin L. Hurd, PhD • Philip J. Landrigan, MD, MSc • Helen S. Mayberg, MD • Diane E. Meier, MD • Eric J. Nestler, MD, PhD • Maria Iandolo New, MD • Peter Palese, PhD • Ramon E. Parsons, MD, PhD • Lynne D. Richardson, MD • Hugh A. Sampson, MD • Albert Siu, MD, MSPH • Barbara G. Vickrey, MD, MPH • Rachel Yehuda, PhD.
Dr. Merad was previously elected to the National Academy of Sciences (NAS) in 2020, one of a very few Icahn Mount Sinai faculty members to hold dual Academy memberships.
New members of the Academy are elected by current members through a process that recognizes individuals who have made major contributions to the advancement of the medical sciences, health care, and public health. For more details, see this year’s official announcement from the National Academy of Medicine: https://nam.edu/news/.
About the Icahn School of Medicine at Mount Sinai
The Icahn School of Medicine at Mount Sinai is internationally renowned for its outstanding research, educational, and clinical care programs. It is the sole academic partner for the eight- member hospitals* of the Mount Sinai Health System, one of the largest academic health systems in the United States, providing care to a large and diverse patient population.
Ranked 14th nationwide in National Institutes of Health (NIH) funding and among the 99th percentile in research dollars per investigator according to the Association of American Medical Colleges, Icahn Mount Sinai has a talented, productive, and successful faculty. More than 3,000 full-time scientists, educators, and clinicians work within and across 44 academic departments and 36 multidisciplinary institutes, a structure that facilitates tremendous collaboration and synergy. Our emphasis on translational research and therapeutics is evident in such diverse areas as genomics/big data, virology, neuroscience, cardiology, geriatrics, as well as gastrointestinal and liver diseases.
Icahn Mount Sinai offers highly competitive MD, PhD, and Master’s degree programs, with current enrollment of approximately 1,300 students. It has the largest graduate medical education program in the country, with more than 2,000 clinical residents and fellows training throughout the Health System. In addition, more than 550 postdoctoral research fellows are in training within the Health System.
A culture of innovation and discovery permeates every Icahn Mount Sinai program. Mount Sinai’s technology transfer office, one of the largest in the country, partners with faculty and trainees to pursue optimal commercialization of intellectual property to ensure that Mount Sinai discoveries and innovations translate into healthcare products and services that benefit the public.
Icahn Mount Sinai’s commitment to breakthrough science and clinical care is enhanced by academic affiliations that supplement and complement the School’s programs.
Through the Mount Sinai Innovation Partners (MSIP), the Health System facilitates the real-world application and commercialization of medical breakthroughs made at Mount Sinai. Additionally, MSIP develops research partnerships with industry leaders such as Merck & Co., AstraZeneca, Novo Nordisk, and others.
The Icahn School of Medicine at Mount Sinai is located in New York City on the border between the Upper East Side and East Harlem, and classroom teaching takes place on a campus facing Central Park. Icahn Mount Sinai’s location offers many opportunities to interact with and care for diverse communities. Learning extends well beyond the borders of our physical campus, to the eight hospitals of the Mount Sinai Health System, our academic affiliates, and globally.
——————————————————-
Media Contact
Karin Eskenazi, Mount Sinai, 332-257-1538, [email protected], mountsinai.org
SOURCE Mount Sinai
TOKYO, Oct. 9, 2023 /PRNewswire/ — On October 5, 2023, Kaneka Corporation filed a lawsuit in the United States District Court for the Eastern District of New York against Cocrystal Technology Co. Ltd. and Cocrystal Health Industry Co. Ltd. (collectively “CoCrystal”) seeking an injunction…
NEW YORK, Oct. 9, 2023 /PRNewswire/ — The teeth whitening tray market size is expected to grow by USD 38.73 million from 2022 to 2027, according to Technavio. In addition, the growth momentum of the market will progress at a CAGR of 3.64% during the forecast period. Increasing awareness…
Those changes include increased fatty tissue deposits and vascular anatomy changes, such as increased arterial stiffness, Dr. Mehta said.
Additionally, research has shown women who experience “premature menopause” – symptoms prior to age 40 – or early menopause (from ages 40-45) also have an increased risk of heart failure or atrial fibrillation, compared to those who begin the menopausal transition at a later age.
“Menopause is not just about hot flashes and reproductive system changes,” Dr. Mehta said. “We want patients to be mindful of the other health risks associated with the menopausal transition, and to take preventive steps – such as prioritizing improved diet and sleep habits – to lessen those risks.”
Nature is a weekly international journal that publishes peer-reviewed research in all fields of science and technology. Nature also publishes review articles, which interpret and contextualize existing research; the AHN-Harvard paper appeared in “Nature Reviews Cardiology,” a monthly journal.
Menopause is an under-researched area of medicine, and the Nature review article was published just a few weeks after the journal Cell published its own comprehensive review of the state of menopausal medicine, looking at 70 years of mid-life research and identifying knowledge gaps.
“Despite decades of research pertaining to menopause, more work is needed to document [symptom] prevalence and health impacts outside high-income countries,” the review said.
Because of those knowledge and research gaps, general awareness about menopause and its many potential side effects is limited.
“While almost all women will experience menopause, only a minority of them receive effective treatment for their symptoms,” said JoAnn E. Manson, MD, of Brigham and Women’s Hospital and the Harvard Medical School.
A pioneering women’s health advocate and oft-cited public health researcher, Dr. Manson is co-author of the Nature article. “The implications are enormous for women, their health, and their general sense of wellness and productivity – one recent study suggested that menopause symptoms cost American women $1.8 billion in lost working time per year.”
As for the cardiovascular risk factors tied to menopause, while changes in men’s body composition occur more gradually, for women, “modifications in body composition occur most rapidly during the two-year period before and after the final menstrual period,” the Nature review article said.
The changes in body composition, fat metabolism, and estrogen levels during menopause are associated with elevated lipid levels, arterial thickening, and other heart health risk factors.
“Cardiovascular disease remains the leading cause of death in women, who tend to develop the disease later in life than men do,” Dr. Manson said. “All women should be mindful of their heart health, but women who are experiencing or about to experience menopause should talk with their doctors about
their unique cardiovascular risk factors.”
The Nature article (doi:10.1038/s41569-023-00926-7) was published Sept. 26.
About the Allegheny Health Network:
Allegheny Health Network (AHN.org), is an integrated healthcare delivery system serving the greater Western Pennsylvania region. The Network is composed of 14 hospitals, ambulatory surgery centers, Health + Wellness Pavilions, multiple employed physician organizations, home and community-based health services, a research institute, and a group purchasing organization. The Network provides patients with access to a complete spectrum of advanced medical services, including nationally recognized programs for primary and emergency care, trauma care, cardiovascular disease, organ transplantation, cancer care, orthopedic surgery, neurology and neurosurgery, women’s health, diabetes, autoimmune disease and more. AHN employs approximately 21,000 people, has more than 2,600 physicians on its medical staff and serves as a clinical campus for Drexel University College of Medicine and the Lake Erie College of Osteopathic Medicine.
Media Contact
Nikki Buccina, Allegheny Health Network, 412-596-2679, [email protected], www.ahn.org
SOURCE Allegheny Health Network
New Jersey Cannabis Regulatory Commission will announce the launch of its statewide public education campaign on safe cannabis use during a press conference on 10/11/23.
TRENTON, N.J., Oct. 9, 2023 /PRNewswire-PRWeb/ —
Contact: Toni-Anne Blake
Email: [email protected]
PRESS CONFERENCE MEDIA ADVISORY
WHAT: The New Jersey Cannabis Regulatory Commission (NJ-CRC) will be launching its statewide public education campaign on safe cannabis use.
WHEN: Wednesday, October 11, 2023 at 10 a.m.
WHERE: 225 East State Street, Suite 5, Trenton (Entrance at Montgomery and State Street)
WHO:
Speakers will include:
PHOTO OPP: Speakers, campaign visuals, safe use packaging examples
Media Contact
Toni-Anne Blake, New Jersey Cannabis Regulatory Commission, 1 609-376-7300, [email protected], https://www.nj.gov/cannabis/
SOURCE New Jersey Cannabis Regulatory Commission
Array Skin Therapy is thrilled to have opened its newest clinic location in La Jolla, California. The brand’s expansion to La Jolla showcases Array Skin Therapy’s commitment to increasing patient access to high-quality, compassionate narrowband UVB phototherapy treatment.
LA JOLLA, Calif., Oct. 9, 2023 /PRNewswire-PRWeb/ — Array Skin Therapy is excited to announce the opening of its newest clinic location in the heart of La Jolla, owned and operated by LP Health and managed by business partners Lynn Pipitone, FNP-C, and Cheryl Salazar. The La Jolla clinic is Array Skin Therapy’s seventh standalone light therapy clinic and its second franchised location. Dr. Brian Levine serves as the clinic’s Medical Director.
The new Array Skin Therapy clinic, located at 3252 Holiday Court, Ste 208, houses top tier light therapy equipment in a calm and relaxed setting. Array Skin Therapy’s dedication to providing standalone light therapy services allows patients to receive their treatments multiple times a week in a quick and convenient manner.
Services Offered
Xtrac excimer laser: targets only affected areas
Booth: full-body cabinets for treating wide-spread symptoms, open-top and do not lock
Hand and foot unit: treats hands and feet without exposing unaffected body areas for targeted treatment
“We are here for people living with chronic skin disorders,” said Lynn Pipitone, N.P., Clinical Director at Array Skin Therapy. “We are happy to offer a safe and effective treatment that can improve the quality of life for those who are living with frustrating symptoms.” To learn more about Array Skin Therapy and its range of light therapy treatments, visit their website at https://arrayskin.com/la-jolla
About Array Skin Therapy
Array Skin Therapy is a first-to-market franchise that provides light therapy to help people find real, long-lasting and affordable solutions to chronic autoimmune and inflammatory skin conditions, including psoriasis, vitiligo, eczema and more.
Media Contact
Cheryl Salazar
Chief Operating Officer
LP Health DBA Array Skin Therapy
858-247-0242
[email protected]
https://arrayskin.com/la-jolla
SOURCE Array Skin Therapy
Media Contact
Cheryl Salazar, Array Skin Therapy, 858-247-0242, [email protected], https://arrayskin.com/la-jolla
SOURCE Array Skin Therapy
Seeing a massive gap in the market for a highly effective vitamin B complex that was also truly USDA Certified Organic and safe, Purity Woods is thrilled to announce an exciting expansion into supplements with the new ORGANIC B COMPLETE.
The USDA Certified Organic Organic B Complete is meticulously crafted from organic whole food ingredients to provide a complete blend of all eight essential B vitamins. The introduction of Organic B Complete signifies an exciting new chapter in Purity Wood’s mission to provide nature’s most potent healthy aging and longevity ingredients in fully USDA Certified Organic formulas.
A Commitment to Purity
Supplements may be the #1 worst “contamination” offender out there when it comes to feeding your body synthetic and toxic ingredients that can work against your health. Supplements often contain artificial sweeteners, dyes, pesticides, artificial preservatives, and high levels of heavy metals.
According to Consumer Reports, 23,000 people annually even end up in the emergency room after taking a supplement.
As consumer awareness about this continues to grow, many supplement companies have resorted to “greenwashing.” They use deceptive promotional phrases like “contains organic ingredients” – but read the label closely. While it may contain some organic ingredients, it can still contain many potentially toxic ingredients as well.
Seeing this need for a highly effective and independently verified organic vitamin B supplement, Purity Woods created Organic B Complete. Organic B Complete is USDA Certified Organic, meaning this vegan, non-GMO, gluten-free formula is free of any synthetic ingredients, pesticides, herbicides, and other potential toxins!
Organic B Complete: Unique for Other Reasons, Too
It can be challenging to get the total daily value of B12 from diet alone, especially for those who eat a plant-based diet, as B12 primarily comes from meat and dairy. Older adults are also likely to be low in B12 due to lower amounts of stomach acid, inhibiting optimal nutritional absorption.
Like all B vitamins, B12 is water-soluble. The body uses what it needs and eliminates the rest, so many experts recommend consuming above the daily value (DV). Organic B Complete provides 1024% of the daily value of a highly absorbable form of vitamin B12. And unlike many supplements that include synthetic forms of this B12, Purity Woods’ is plant-based and naturally fermented, making it more bioavailable.
In addition, Organic B Complete provides highly effective forms of the other seven essential B vitamins from whole food sources – such as organic beet root and organic holy basil – that all exceed the DV.
Founder’s Statement
From the start, Purity Woods’ mission has been to provide nature’s most potent ingredients for healthy aging so no one has to worry about harming their health with toxins that are so common in products today.
We’ve become well-known for our highly effective organic skincare products that use nature’s best ingredients to eliminate the appearance of wrinkles, age spots, and other signs of early aging like nothing else can.
However, the supplement industry is now saturated with low-quality products that contain synthetic and toxic ingredients that do not belong in people’s bodies. In fact, supplements in general may be even more contaminated than most cosmetic products out there, and that’s saying a lot.
Because so many of our customers are plant-based eaters in their 40s, 50s, 60s and beyond, working hard to provide a truly organic supplement with all eight essential vitamin Bs was simply the right thing to do. That’s why we’re so excited about offering this first supplement in our USDA Certified Organic lineup!
Sustainable and Cruelty-Free
Because trees are so vital to our health, and because so many trees have been lost to forest fires, we donate a portion of proceeds from every order to One Tree Planted, a nonprofit dedicated to planting trees in devastated regions.
The esteemed Leaping Bunny certification is granted only to products that can verify they’re 100% cruelty-free. We are proud that all of Purity Woods’s products, including Organic B Complete, have achieved this special certification.
Contact + More
Purity Woods’ Organic B Complete is available for purchase now on puritywoods.com for up to 32% off, plus free U.S. shipping. For more information about Organic B Complete and Purity Woods, please contact Billie Schaub at [email protected].
Media Contact
Billie Schaub, Purity Woods, 1 818-621-7665, [email protected], https://puritywoods.com/
Anita Elisha, Purity Woods, 1 514-867-9360, [email protected], https://puritywoods.com/
SOURCE Purity Woods
Bonita Pharmaceuticals, a pioneering name in the pharmaceutical industry, is excited to announce its participation in the highly anticipated NCPA 2023 Annual Convention and Expo.
ORANGE COUNTY CONVENTION CENTER ORLANDO, Fla., Oct. 9, 2023 /PRNewswire-PRWeb/ — Bonita Pharmaceuticals, a pioneering name in the pharmaceutical industry, is excited to announce its participation in the highly anticipated NCPA 2023 Annual Convention and Expo. This convention stands as a significant opportunity for Bonita Pharma to engage with the independent pharmacy community, share insights, and contribute to the ongoing transformation of the pharmacy landscape.
ABOUT BONITA PHARMACEUTICALS
Bonita Pharmaceuticals is a licensed wholesale distributor. Bonita Pharmaceuticals have licensed to serve 47 states across the country. We provide a wide variety of FDA-approved products, including Generics, Brands, and Over-the-Counter Medications. We provide our services to Retail Chains, Independent Retail Pharmacies, Wholesale Distributors, and Institutional Providers such as Hospitals, Health Systems, Integrated Delivery Networks, and Long-Term Care Providers. For more information: http://www.bonitapharma.com
ABOUT NCPA ANNUAL CONVENTION AND EXPO
The NCPA Annual Convention is a distinguished national business show designed exclusively for independent pharmacists and their teams. This event holds a unique place on the calendar, offering attendees unparalleled peer-to-peer business education, comprehensive continuing education sessions, and invaluable networking opportunities with both familiar faces and new connections. The Expo Hall showcases companies with cutting-edge products and services that empower independent pharmacists to enhance their businesses’ efficiency and profitability. The NCPA Annual Convention is a can’t-miss event for anyone invested in the future of pharmacy.
For more information about the NCPA 2023 Annual Convention and Expo, please visit https://ncpa.org/annual-convention
Bonita Pharma eagerly anticipates joining the independent pharmacy community at the NCPA Annual Convention and Expo 2023, collaborating to innovate and elevate the future of pharmacy.
For More Information:
Phone: 734-729-7200
Email: [email protected]
Amen Ramouni, Bonita Pharmaceuticals, +1(734) 729-7200 361, [email protected], bonitapharma.com
SOURCE Bonita Pharmaceuticals
SightMD, a leading multi-specialty ophthalmology platform in New York, welcomes Reena Patel, OD to its expert team.
HAUPPAUGE, N.Y., Oct. 9, 2023 /PRNewswire-PRWeb/ — SightMD, a leading multi-specialty ophthalmology platform in New York, welcomes Reena Patel, OD to its expert team.
Dr. Reena Patel is a board certified Optometric physician who is committed to providing the highest level of care for all her patients. Dr. Patel earned her Bachelor of Science degree in Optometry and Visual Science from City University London. While in the UK, she practiced optometry in the Greater London area, where she performed comprehensive eye exams, contact lens fittings and ocular disease management for patients of all ages. After relocating to the United States, she attended New England College of Optometry to obtain her doctorate degree and graduated from the Advanced Standing International Program. She then went on to complete her residency at Nova Southeastern University with a focus in Primary Care and Ocular Disease. She focuses on educating patients on their ocular health and providing solutions to their concerns. Dr Patel takes pride in that her patients leave feeling they had an overall great experience. She also has an interest in training and teaching future physicians. In her spare time Dr Patel enjoys reading, cooking, the arts, and spending time outdoors.
Dr. Reena Patel will be seeing patients at our Brooklyn location (902 49th St, Brooklyn, NY 11219).
When asked what excites her most about joining the SightMD team, Dr. Patel said “I’m looking forward to joining a team that equally focuses on providing the highest level of patient care, as well as working alongside doctors from every speciality of ophthalmology.”
SightMD is actively seeking ophthalmology professionals who are interested in joining our outstanding team. If you are an ophthalmology practice owner interested in merging or selling your practice, please contact our VP of Growth, Franc Galinanes, at (631) 396-8340 or [email protected]
About SightMD
SightMD is a rapidly-growing integrated ophthalmic provider group, offering patients access to over 80 eye care providers through the convenience of 40 locations across New York. SightMD’s track record of providing clinically-excellent care spans over 50 years, and its services include general eye exams, laser cataract surgery and lens implantation, glaucoma management, retinal disorder treatment, corneal services, neuro-ophthalmology, LASIK laser vision correction, oculoplastic surgery, pediatric ophthalmology, and audiology. Sight Growth Partners is the administrative services provider for SightMD as well as SightMD Connecticut, SightMD New Jersey, and SightMD Pennsylvania. For more information about SightMD, please visit https://www.sightmd.com/sightmd-ny/
Media Contact
Stephanie Penza, SightGrowthPartners, 6318352613, [email protected]
SOURCE SightGrowthPartners
